$31.90
-0.09 (-0.28%)
Bristol-Myers Squibb Co. (NYSE:BMY)
CAPS Rating:
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
As safe as they come in this industry. While it has potential challenges with patent expirations especially with Plavix, it has an underrated pipeline, strong balance sheet and a solid, dependable 5% dividend (hasn't missed a dividend payment in over 50 years!). In this uncertain market, this is stock that you can buy and sleep easy on.